Pancreatic 18F-FDG uptake is increased in type 2 diabetes patients compared to non-diabetic controls

Increasing evidence indicates that the development of type 2 diabetes is driven by chronic low grade beta-cell inflammation. However, it is unclear whether pancreatic inflammation can be noninvasively visualized in type 2 diabetes patients. We aimed to assess pancreatic 18F-FDG uptake in type 2 diab...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 14; no. 3; p. e0213202
Main Authors Bakker, Guido J., Vanbellinghen, Manon C., Scheithauer, Torsten P., Verchere, C. Bruce, Stroes, Erik S., Timmers, Nyanza K. L. M., Herrema, Hilde, Nieuwdorp, Max, Verberne, Hein J., van Raalte, Daniël H.
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 2019
Public Library of Science (PLoS)
Subjects
Online AccessGet full text
ISSN1932-6203
1932-6203
DOI10.1371/journal.pone.0213202

Cover

Loading…
Abstract Increasing evidence indicates that the development of type 2 diabetes is driven by chronic low grade beta-cell inflammation. However, it is unclear whether pancreatic inflammation can be noninvasively visualized in type 2 diabetes patients. We aimed to assess pancreatic 18F-FDG uptake in type 2 diabetes patients and controls using 18F-fluorodeoxylglucose positron emission tomography/computed tomography (18F-FDG PET/CT). In this retrospective cross-sectional study, we enrolled 20 type 2 diabetes patients and 65 controls who had undergone a diagnostic 18F-FDG PET/CT scan and obtained standardized uptake values (SUVs) of pancreas and muscle. Pancreatic SUV was adjusted for background uptake in muscle and for fasting blood glucose concentrations. The maximum pancreatic SUVs adjusted for background muscle uptake (SUVmax.m) and fasting blood glucose concentration (SUVglucose) were significantly higher in diabetes patients compared to controls (median 2.86 [IQR 2.24-4.36] compared to 2.15 [IQR 1.51-2.83], p = 0.006 and median 2.76 [IQR 1.18-4.34] compared to 1.91 [IQR 1.27-2.55], p<0.001, respectively). In linear regression adjusting for age and body mass index, diabetes remained the main predictor of SUVmax.m and SUVglucose. Pancreatic 18F-FDG uptake adjusted for background muscle uptake and fasting blood glucose concentration was significantly increased in type 2 diabetes patients.
AbstractList Introduction Increasing evidence indicates that the development of type 2 diabetes is driven by chronic low grade beta-cell inflammation. However, it is unclear whether pancreatic inflammation can be noninvasively visualized in type 2 diabetes patients. We aimed to assess pancreatic 18F-FDG uptake in type 2 diabetes patients and controls using 18F-fluorodeoxylglucose positron emission tomography/computed tomography (18F-FDG PET/CT). Material and methods In this retrospective cross-sectional study, we enrolled 20 type 2 diabetes patients and 65 controls who had undergone a diagnostic 18F-FDG PET/CT scan and obtained standardized uptake values (SUVs) of pancreas and muscle. Pancreatic SUV was adjusted for background uptake in muscle and for fasting blood glucose concentrations. Results The maximum pancreatic SUVs adjusted for background muscle uptake (SUVmax.m) and fasting blood glucose concentration (SUVglucose) were significantly higher in diabetes patients compared to controls (median 2.86 [IQR 2.24–4.36] compared to 2.15 [IQR 1.51–2.83], p = 0.006 and median 2.76 [IQR 1.18–4.34] compared to 1.91 [IQR 1.27–2.55], p<0.001, respectively). In linear regression adjusting for age and body mass index, diabetes remained the main predictor of SUVmax.m and SUVglucose. Conclusion Pancreatic 18F-FDG uptake adjusted for background muscle uptake and fasting blood glucose concentration was significantly increased in type 2 diabetes patients.
Introduction Increasing evidence indicates that the development of type 2 diabetes is driven by chronic low grade beta-cell inflammation. However, it is unclear whether pancreatic inflammation can be noninvasively visualized in type 2 diabetes patients. We aimed to assess pancreatic 18F-FDG uptake in type 2 diabetes patients and controls using 18F-fluorodeoxylglucose positron emission tomography/computed tomography (18F-FDG PET/CT). Material and methods In this retrospective cross-sectional study, we enrolled 20 type 2 diabetes patients and 65 controls who had undergone a diagnostic 18F-FDG PET/CT scan and obtained standardized uptake values (SUVs) of pancreas and muscle. Pancreatic SUV was adjusted for background uptake in muscle and for fasting blood glucose concentrations. Results The maximum pancreatic SUVs adjusted for background muscle uptake (SUVmax.m) and fasting blood glucose concentration (SUVglucose) were significantly higher in diabetes patients compared to controls (median 2.86 [IQR 2.24–4.36] compared to 2.15 [IQR 1.51–2.83], p = 0.006 and median 2.76 [IQR 1.18–4.34] compared to 1.91 [IQR 1.27–2.55], p<0.001, respectively). In linear regression adjusting for age and body mass index, diabetes remained the main predictor of SUVmax.m and SUVglucose. Conclusion Pancreatic 18F-FDG uptake adjusted for background muscle uptake and fasting blood glucose concentration was significantly increased in type 2 diabetes patients.
Increasing evidence indicates that the development of type 2 diabetes is driven by chronic low grade beta-cell inflammation. However, it is unclear whether pancreatic inflammation can be noninvasively visualized in type 2 diabetes patients. We aimed to assess pancreatic 18F-FDG uptake in type 2 diabetes patients and controls using 18F-fluorodeoxylglucose positron emission tomography/computed tomography (18F-FDG PET/CT). In this retrospective cross-sectional study, we enrolled 20 type 2 diabetes patients and 65 controls who had undergone a diagnostic 18F-FDG PET/CT scan and obtained standardized uptake values (SUVs) of pancreas and muscle. Pancreatic SUV was adjusted for background uptake in muscle and for fasting blood glucose concentrations. The maximum pancreatic SUVs adjusted for background muscle uptake (SUVmax.m) and fasting blood glucose concentration (SUVglucose) were significantly higher in diabetes patients compared to controls (median 2.86 [IQR 2.24-4.36] compared to 2.15 [IQR 1.51-2.83], p = 0.006 and median 2.76 [IQR 1.18-4.34] compared to 1.91 [IQR 1.27-2.55], p<0.001, respectively). In linear regression adjusting for age and body mass index, diabetes remained the main predictor of SUVmax.m and SUVglucose. Pancreatic 18F-FDG uptake adjusted for background muscle uptake and fasting blood glucose concentration was significantly increased in type 2 diabetes patients.
Increasing evidence indicates that the development of type 2 diabetes is driven by chronic low grade beta-cell inflammation. However, it is unclear whether pancreatic inflammation can be noninvasively visualized in type 2 diabetes patients. We aimed to assess pancreatic 18F-FDG uptake in type 2 diabetes patients and controls using 18F-fluorodeoxylglucose positron emission tomography/computed tomography (18F-FDG PET/CT).INTRODUCTIONIncreasing evidence indicates that the development of type 2 diabetes is driven by chronic low grade beta-cell inflammation. However, it is unclear whether pancreatic inflammation can be noninvasively visualized in type 2 diabetes patients. We aimed to assess pancreatic 18F-FDG uptake in type 2 diabetes patients and controls using 18F-fluorodeoxylglucose positron emission tomography/computed tomography (18F-FDG PET/CT).In this retrospective cross-sectional study, we enrolled 20 type 2 diabetes patients and 65 controls who had undergone a diagnostic 18F-FDG PET/CT scan and obtained standardized uptake values (SUVs) of pancreas and muscle. Pancreatic SUV was adjusted for background uptake in muscle and for fasting blood glucose concentrations.MATERIAL AND METHODSIn this retrospective cross-sectional study, we enrolled 20 type 2 diabetes patients and 65 controls who had undergone a diagnostic 18F-FDG PET/CT scan and obtained standardized uptake values (SUVs) of pancreas and muscle. Pancreatic SUV was adjusted for background uptake in muscle and for fasting blood glucose concentrations.The maximum pancreatic SUVs adjusted for background muscle uptake (SUVmax.m) and fasting blood glucose concentration (SUVglucose) were significantly higher in diabetes patients compared to controls (median 2.86 [IQR 2.24-4.36] compared to 2.15 [IQR 1.51-2.83], p = 0.006 and median 2.76 [IQR 1.18-4.34] compared to 1.91 [IQR 1.27-2.55], p<0.001, respectively). In linear regression adjusting for age and body mass index, diabetes remained the main predictor of SUVmax.m and SUVglucose.RESULTSThe maximum pancreatic SUVs adjusted for background muscle uptake (SUVmax.m) and fasting blood glucose concentration (SUVglucose) were significantly higher in diabetes patients compared to controls (median 2.86 [IQR 2.24-4.36] compared to 2.15 [IQR 1.51-2.83], p = 0.006 and median 2.76 [IQR 1.18-4.34] compared to 1.91 [IQR 1.27-2.55], p<0.001, respectively). In linear regression adjusting for age and body mass index, diabetes remained the main predictor of SUVmax.m and SUVglucose.Pancreatic 18F-FDG uptake adjusted for background muscle uptake and fasting blood glucose concentration was significantly increased in type 2 diabetes patients.CONCLUSIONPancreatic 18F-FDG uptake adjusted for background muscle uptake and fasting blood glucose concentration was significantly increased in type 2 diabetes patients.
IntroductionIncreasing evidence indicates that the development of type 2 diabetes is driven by chronic low grade beta-cell inflammation. However, it is unclear whether pancreatic inflammation can be noninvasively visualized in type 2 diabetes patients. We aimed to assess pancreatic 18F-FDG uptake in type 2 diabetes patients and controls using 18F-fluorodeoxylglucose positron emission tomography/computed tomography (18F-FDG PET/CT).Material and methodsIn this retrospective cross-sectional study, we enrolled 20 type 2 diabetes patients and 65 controls who had undergone a diagnostic 18F-FDG PET/CT scan and obtained standardized uptake values (SUVs) of pancreas and muscle. Pancreatic SUV was adjusted for background uptake in muscle and for fasting blood glucose concentrations.ResultsThe maximum pancreatic SUVs adjusted for background muscle uptake (SUVmax.m) and fasting blood glucose concentration (SUVglucose) were significantly higher in diabetes patients compared to controls (median 2.86 [IQR 2.24-4.36] compared to 2.15 [IQR 1.51-2.83], p = 0.006 and median 2.76 [IQR 1.18-4.34] compared to 1.91 [IQR 1.27-2.55], p<0.001, respectively). In linear regression adjusting for age and body mass index, diabetes remained the main predictor of SUVmax.m and SUVglucose.ConclusionPancreatic 18F-FDG uptake adjusted for background muscle uptake and fasting blood glucose concentration was significantly increased in type 2 diabetes patients.
Author Bakker, Guido J.
Verchere, C. Bruce
Nieuwdorp, Max
van Raalte, Daniël H.
Herrema, Hilde
Timmers, Nyanza K. L. M.
Verberne, Hein J.
Scheithauer, Torsten P.
Vanbellinghen, Manon C.
Stroes, Erik S.
AuthorAffiliation 6 ICaR, Amsterdam University Medical Centers, Amsterdam, The Netherlands
7 Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands
4 Department of Surgery and Department of Pathology and Laboratory Medicine, BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
1 Department of Vascular Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands
Mahidol University, THAILAND
3 Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands
2 Department of Experimental Vascular Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands
5 Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
AuthorAffiliation_xml – name: 2 Department of Experimental Vascular Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands
– name: 5 Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
– name: Mahidol University, THAILAND
– name: 7 Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands
– name: 4 Department of Surgery and Department of Pathology and Laboratory Medicine, BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
– name: 1 Department of Vascular Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands
– name: 3 Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands
– name: 6 ICaR, Amsterdam University Medical Centers, Amsterdam, The Netherlands
Author_xml – sequence: 1
  givenname: Guido J.
  orcidid: 0000-0002-2819-9395
  surname: Bakker
  fullname: Bakker, Guido J.
– sequence: 2
  givenname: Manon C.
  surname: Vanbellinghen
  fullname: Vanbellinghen, Manon C.
– sequence: 3
  givenname: Torsten P.
  surname: Scheithauer
  fullname: Scheithauer, Torsten P.
– sequence: 4
  givenname: C. Bruce
  surname: Verchere
  fullname: Verchere, C. Bruce
– sequence: 5
  givenname: Erik S.
  surname: Stroes
  fullname: Stroes, Erik S.
– sequence: 6
  givenname: Nyanza K. L. M.
  surname: Timmers
  fullname: Timmers, Nyanza K. L. M.
– sequence: 7
  givenname: Hilde
  surname: Herrema
  fullname: Herrema, Hilde
– sequence: 8
  givenname: Max
  surname: Nieuwdorp
  fullname: Nieuwdorp, Max
– sequence: 9
  givenname: Hein J.
  surname: Verberne
  fullname: Verberne, Hein J.
– sequence: 10
  givenname: Daniël H.
  surname: van Raalte
  fullname: van Raalte, Daniël H.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30889184$$D View this record in MEDLINE/PubMed
BookMark eNp9Ustu1DAUtVARbQf-AIElNt3M4Ff8YIGESqdUqgQLWFs3jqd4yMTBTpD693gmadVWiJWvfM8599zHKTrqYucRek3JinJF32_jmDpoV335XhFGOSPsGTqhhrOlZIQfPYiP0WnOW0IqrqV8gY450dpQLU5Q8w06lzwMwWGq18v150s89gP88jhkHA657JsS4eG295jhJkDtB59xX0i-GzJ2cddDKqAh4mJyOSGKoIvdkGKbX6LnG2izfzW_C_RjffH9_Mvy-uvl1fmn66UrDR2cekd9RY2qDKl0bTxlTIJuwDChuTQcgDqlGtZQUWunhVSFqbVTTijFF-jtpNu3Mdt5QNkyaoQ0RJRBLNDVhGgibG2fwg7SrY0Q7OEjphsLqVhvvYUKKK0bwjdyI5jjxtWlmNISPKkl10Xr41xtrHe-cWUWCdpHoo8zXfhpb-IfKwUT3OzNnM0CKf4efR7sLmTn2xY6H8fJd6WZolWBvnsC_Xd3bx46urdyt-4CEBPApZhz8pt7CCV2f1V3snZ_VXa-qkL78ITmwlC2v18vhPb_5L_YU9Qi
CitedBy_id crossref_primary_10_1053_j_semnuclmed_2020_04_002
crossref_primary_10_2214_AJR_20_24567
crossref_primary_10_3390_s21206820
Cites_doi 10.2337/dc14-0396
10.1126/science.1104345
10.1016/S0140-6736(09)60619-X
10.1016/S0140-6736(11)60614-4
10.1210/jc.2008-0396
10.2967/jnumed.113.131847
10.2337/diab.23.8.713
10.2337/dc14-2459
10.1210/jc.2013-4369
10.2337/dc10-0004
10.1007/s00125-009-1410-z
10.1016/S0140-6736(11)61383-4
10.1172/JCI7231
10.1016/j.cmet.2013.05.001
10.1186/s12872-016-0397-x
10.1093/annonc/10.suppl_4.S28
10.1016/j.diabres.2005.04.008
10.1210/en.2009-0543
10.2337/db13-0863
10.2337/diabetes.48.11.2197
10.1093/cid/cis193
10.1111/dom.12168
10.2337/diab.44.12.1386
10.2337/db06-1650
ContentType Journal Article
Copyright 2019 Bakker et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2019 Bakker et al 2019 Bakker et al
Copyright_xml – notice: 2019 Bakker et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2019 Bakker et al 2019 Bakker et al
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0213202
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database (ProQuest)
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Materials Science Collection
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Collection (ProQuest)
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agricultural Science Database
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Agricultural Science Database

MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
DocumentTitleAlternate Pancreatic 18F-FDG uptake in type 2 diabetes
EISSN 1932-6203
ExternalDocumentID 2194690420
oai_doaj_org_article_a5a11bd03f6f42c39cb737786ae0b638
PMC6424390
30889184
10_1371_journal_pone_0213202
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Netherlands
GeographicLocations_xml – name: Netherlands
GrantInformation_xml – fundername: ;
  grantid: talent grant
– fundername: ;
  grantid: Junior Fellowship (2015.81.1840)
– fundername: ;
  grantid: VIDI grant 2013 (016.146.327)
– fundername: ;
  grantid: Young Talent grant 2012
– fundername: ;
  grantid: Global Fellowship (708193)
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
3V.
ADRAZ
BBORY
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
RIG
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
7X8
5PM
PUEGO
AAPBV
ABPTK
N95
ID FETCH-LOGICAL-c3712-620ec1e519759058b9e1226a8da92483693aa1c77d2d14b8c846737188c7c4773
IEDL.DBID 7X7
ISSN 1932-6203
IngestDate Sun Aug 06 00:16:19 EDT 2023
Wed Aug 27 01:24:45 EDT 2025
Thu Aug 21 13:38:54 EDT 2025
Mon Jul 21 11:22:46 EDT 2025
Sat Aug 23 13:36:46 EDT 2025
Wed Feb 19 02:30:55 EST 2025
Tue Jul 01 01:43:00 EDT 2025
Thu Apr 24 23:12:39 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3712-620ec1e519759058b9e1226a8da92483693aa1c77d2d14b8c846737188c7c4773
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Competing Interests: The authors have declared that no competing interests exist.
ORCID 0000-0002-2819-9395
OpenAccessLink https://www.proquest.com/docview/2194690420?pq-origsite=%requestingapplication%
PMID 30889184
PQID 2194690420
PQPubID 1436336
ParticipantIDs plos_journals_2194690420
doaj_primary_oai_doaj_org_article_a5a11bd03f6f42c39cb737786ae0b638
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6424390
proquest_miscellaneous_2194582715
proquest_journals_2194690420
pubmed_primary_30889184
crossref_primary_10_1371_journal_pone_0213202
crossref_citationtrail_10_1371_journal_pone_0213202
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-00-00
PublicationDateYYYYMMDD 2019-01-01
PublicationDate_xml – year: 2019
  text: 2019-00-00
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2019
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References K Eguchi (ref11) 2013; 15
JB O’Sullivan (ref25) 1974; 23
SJ Richardson (ref10) 2009; 52
CY Westwell-Roper (ref7) 2014; 63
C Weyer (ref3) 1999; 48
AG Tabak (ref21) 2009; 373
M Zimny (ref26) 1999; 10
CJ Rhodes (ref6) 2005; 307
A Haroon (ref16) 2012; 54
ZA Fayad (ref19) 2011; 378
T Torizuka (ref28) 1997; 38
MY Donath (ref14) 2013; 17
T Kalliokoski (ref24) 2005; 70
SM Haffner (ref1) 1995; 44
JW Lee (ref20) 2014; 55
CJ Nolan (ref5) 2011; 378
MY Donath (ref13) 2009; 24
PA Halban (ref15) 2014; 37
M Boni-Schnetzler (ref8) 2008; 93
CG Diederichs (ref27) 1998; 39
T Mochizuki (ref17) 2001; 42
F Bacha (ref4) 2010; 33
JA Ehses (ref9) 2007; 56
C Weyer (ref2) 1999; 104
SJ Bernelot Moens (ref18) 2016; 16
M Boni-Schnetzler (ref12) 2009; 150
H Honka (ref23) 2014; 99
WH Herman (ref22) 2015; 38
References_xml – volume: 37
  start-page: 1751
  issue: 6
  year: 2014
  ident: ref15
  article-title: beta-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment
  publication-title: Diabetes Care
  doi: 10.2337/dc14-0396
– volume: 307
  start-page: 380
  issue: 5708
  year: 2005
  ident: ref6
  article-title: Type 2 diabetes-a matter of beta-cell life and death?
  publication-title: Science
  doi: 10.1126/science.1104345
– volume: 373
  start-page: 2215
  issue: 9682
  year: 2009
  ident: ref21
  article-title: Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(09)60619-X
– volume: 378
  start-page: 169
  issue: 9786
  year: 2011
  ident: ref5
  article-title: Type 2 diabetes across generations: from pathophysiology to prevention and management
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)60614-4
– volume: 93
  start-page: 4065
  issue: 10
  year: 2008
  ident: ref8
  article-title: Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2008-0396
– volume: 55
  start-page: 898
  issue: 6
  year: 2014
  ident: ref20
  article-title: Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients with Pancreatic Cancer
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.113.131847
– volume: 23
  start-page: 713
  issue: 8
  year: 1974
  ident: ref25
  article-title: Age gradient in blood glucose levels. Magnitude and clinical implications
  publication-title: Diabetes
  doi: 10.2337/diab.23.8.713
– volume: 38
  start-page: 1449
  issue: 8
  year: 2015
  ident: ref22
  article-title: Early Detection and Treatment of Type 2 Diabetes Reduce Cardiovascular Morbidity and Mortality: A Simulation of the Results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe)
  publication-title: Diabetes Care
  doi: 10.2337/dc14-2459
– volume: 99
  start-page: E981
  issue: 6
  year: 2014
  ident: ref23
  article-title: Pancreatic metabolism, blood flow, and beta-cell function in obese humans
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2013-4369
– volume: 33
  start-page: 2225
  issue: 10
  year: 2010
  ident: ref4
  article-title: From pre-diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation
  publication-title: Diabetes Care
  doi: 10.2337/dc10-0004
– volume: 52
  start-page: 1686
  issue: 8
  year: 2009
  ident: ref10
  article-title: Islet-associated macrophages in type 2 diabetes
  publication-title: Diabetologia
  doi: 10.1007/s00125-009-1410-z
– volume: 378
  start-page: 1547
  issue: 9802
  year: 2011
  ident: ref19
  article-title: Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)61383-4
– volume: 104
  start-page: 787
  issue: 6
  year: 1999
  ident: ref2
  article-title: The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
  publication-title: J Clin Invest
  doi: 10.1172/JCI7231
– volume: 17
  start-page: 860
  issue: 6
  year: 2013
  ident: ref14
  article-title: Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2013.05.001
– volume: 16
  start-page: 237
  issue: 1
  year: 2016
  ident: ref18
  article-title: Carotid arterial wall inflammation in peripheral artery disease is augmented by type 2 diabetes: a cross-sectional study
  publication-title: BMC Cardiovasc Disord
  doi: 10.1186/s12872-016-0397-x
– volume: 10
  start-page: 28
  issue: Suppl 4
  year: 1999
  ident: ref26
  article-title: 18FDG-positron emission tomography in pancreatic cancer
  publication-title: Ann Oncol
  doi: 10.1093/annonc/10.suppl_4.S28
– volume: 42
  start-page: 1551
  issue: 10
  year: 2001
  ident: ref17
  article-title: FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models
  publication-title: J Nucl Med
– volume: 39
  start-page: 1030
  issue: 6
  year: 1998
  ident: ref27
  article-title: FDG PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies
  publication-title: J Nucl Med
– volume: 38
  start-page: 382
  issue: 3
  year: 1997
  ident: ref28
  article-title: Effect of hyperglycemia on in vitro tumor uptake of tritiated FDG, thymidine, L-methionine and L-leucine
  publication-title: J Nucl Med
– volume: 70
  start-page: 217
  issue: 3
  year: 2005
  ident: ref24
  article-title: An autoradiographic study of [(18)F]FDG uptake to islets of Langerhans in NOD mouse
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2005.04.008
– volume: 150
  start-page: 5218
  issue: 12
  year: 2009
  ident: ref12
  article-title: Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I
  publication-title: Endocrinology
  doi: 10.1210/en.2009-0543
– volume: 24
  start-page: 325
  year: 2009
  ident: ref13
  article-title: Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes
  publication-title: Physiology (Bethesda)
– volume: 63
  start-page: 1698
  issue: 5
  year: 2014
  ident: ref7
  article-title: Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1beta production and beta-cell dysfunction
  publication-title: Diabetes
  doi: 10.2337/db13-0863
– volume: 48
  start-page: 2197
  issue: 11
  year: 1999
  ident: ref3
  article-title: Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance
  publication-title: Diabetes
  doi: 10.2337/diabetes.48.11.2197
– volume: 54
  start-page: 1333
  issue: 9
  year: 2012
  ident: ref16
  article-title: Role of fluorine 18 fluorodeoxyglucose positron emission tomography-computed tomography in focal and generalized infectious and inflammatory disorders
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cis193
– volume: 15
  start-page: 152
  issue: Suppl 3
  year: 2013
  ident: ref11
  article-title: Macrophages and islet inflammation in type 2 diabetes
  publication-title: Diabetes Obes Metab
  doi: 10.1111/dom.12168
– volume: 44
  start-page: 1386
  issue: 12
  year: 1995
  ident: ref1
  article-title: Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans
  publication-title: Diabetes
  doi: 10.2337/diab.44.12.1386
– volume: 56
  start-page: 2356
  issue: 9
  year: 2007
  ident: ref9
  article-title: Increased number of islet-associated macrophages in type 2 diabetes
  publication-title: Diabetes
  doi: 10.2337/db06-1650
SSID ssj0053866
Score 2.2754233
Snippet Increasing evidence indicates that the development of type 2 diabetes is driven by chronic low grade beta-cell inflammation. However, it is unclear whether...
Introduction Increasing evidence indicates that the development of type 2 diabetes is driven by chronic low grade beta-cell inflammation. However, it is...
IntroductionIncreasing evidence indicates that the development of type 2 diabetes is driven by chronic low grade beta-cell inflammation. However, it is unclear...
Introduction Increasing evidence indicates that the development of type 2 diabetes is driven by chronic low grade beta-cell inflammation. However, it is...
SourceID plos
doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e0213202
SubjectTerms Aged
Beta cells
Biology and Life Sciences
Blood
Blood Glucose - analysis
Blood levels
Body mass
Body mass index
Body size
Computed tomography
Cross-Sectional Studies
Diabetes
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - metabolism
Diabetes Mellitus, Type 2 - pathology
Diagnostic systems
Family medical history
Fasting
Female
Fluorine isotopes
Fluorodeoxyglucose F18 - chemistry
Fluorodeoxyglucose F18 - metabolism
Glucose
Humans
Hyperglycemia
Inflammation
Insulin
Internal medicine
Laboratories
Linear Models
Male
Medical imaging
Medicine and Health Sciences
Metabolism
Middle Aged
Muscles
Muscles - metabolism
Nuclear medicine
Pancreas
Pancreas - metabolism
Pancreatic cancer
Patients
Physical Sciences
Positron emission
Positron emission tomography
Positron Emission Tomography Computed Tomography
Radiopharmaceuticals - chemistry
Radiopharmaceuticals - metabolism
Research and Analysis Methods
Retrospective Studies
Tomography
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NT9wwEB0hTr1U0FJISysj9UAPhtiO4_jYAguqBOqhSNwif626KkpWze7_7zh2VmyFxKW3KLYTxzP2vBlPngE-C8mClN5SHaSnlfCcam845dzP0SC4YOfxB-fbu_rmvvr-IB-eHPUVc8ISPXAauHMjDWPWl2JeY2MntLNKRNIzE0qLyhNXX7R5kzOV1mCcxXWdf5QTip1nuZwt-y6coVWLh4ZvGaKRrz_ymz72w3NY89-UySc2aLYHrzN4JF9Tp_dhJ3RvYD9Pz4GcZg7pL2_B_0BpjnjQEdbM6OzymqyXK_M7kMVAFmPZEDxekRiEJZxMQViSmVYHMqWnk1VPur6jqQY-MKe3DwdwP7v6eXFD84EK1OEocFrzMjiUDdNK6lI2VgeG8Ms03qAb1ohaC2OYU8pzzyrbuAhOsGXTOOUqpcQ72MX3hSMgobKisvg8XKWqOaIOF2TQTgXrJPogvgAxjW7rMtt4PPTisR230BR6HWnM2iiTNsukALpptUxsGy_U_xYFt6kbubLHG6hBbdag9iUNKuAoin16wdDiIh6DBhUvCzieVOH54pNNMc7KuNViutCvUx3ZcMVkAYdJczadFDGzDB3rAtSWTm19xXZJt_g1Mn-js4gAsnz_Pz77A7xC8KdTOOkYdld_1uEjAqyV_TTOpb9GUSSf
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwEB6VcuGCWl5NW5CROMDBq9iO4-SAqvJYKqQiDqzUW-TXwopVst3sSvDvGSdOxKIFblH89sx4vvFjBuCFkMxL6QwtvXQ0E47T0mlOOXdzVAjWm3l44Hz9Kb-aZR9v5M0BDDFb4wS2e027EE9qtl5Oftz-vECBf91FbVBsKDRZNbWfoM4KIcHvwF3UTSqI6nU2niugdOd5fED3t5I7Cqrz4x_8ni6bdh8G_fMq5W-6aXoE9yOoJJc9FxzDga8fwHEU25a8jL6lXz0E9xmp3OFES1gxpdN3H8h2tdHfPVm0ZNGltd7hFwmbs4STYXOWRA-sLRmurZNNQ-qmpn0OrDBee28fwWz6_svbKxoDLVCLs8BpzlNvkWasVLJMZWFKzxCW6cJpNM8KkZdCa2aVctyxzBQ2gBYsWRRW2Uwp8RgOsT1_AsRnRmQG68PVK5sjGrFe-tIqb6xE28QlIIbZrWz0Qh6CYSyr7mhNoTXSz1kVaFJFmiRAx1Kr3gvHf_K_CYQb8wYf2t2PZv21iiJZaakZMy4V8xzZ0orSGhyUKnLtU4PLUgIngexDA22Fi3vYTMh4msD5wAr7k5-PySit4QhG177Z9nlkwRWTCTzpOWfspAg3ztDgTkDt8NTOKHZT6sW3ziM4GpEILNPTf3frDO4h3Cv7DaRzONyst_4pQqqNedZJyS_o0SHQ
  priority: 102
  providerName: Scholars Portal
Title Pancreatic 18F-FDG uptake is increased in type 2 diabetes patients compared to non-diabetic controls
URI https://www.ncbi.nlm.nih.gov/pubmed/30889184
https://www.proquest.com/docview/2194690420
https://www.proquest.com/docview/2194582715
https://pubmed.ncbi.nlm.nih.gov/PMC6424390
https://doaj.org/article/a5a11bd03f6f42c39cb737786ae0b638
http://dx.doi.org/10.1371/journal.pone.0213202
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELagvXBBlFcDZWUkDnBwG79i54RoaVohtaoQlfYW-bVlRZUsze7_Z5w4gUUVXKwofiTxzNjfjCczCL3jkgYpvSVlkJ4I7hkpvWGEMb-ADcEFu4g_OF9cFufX4stczpPBrUtuleOa2C_UvnXRRn4EkhU1OcHyj6ufJGaNiqerKYXGQ7QbQ5dFly41nxQukOWiSL_LcUWPEnUOV20TDmFvi6nDt7ajPmp_jHJ623b3Ic6_HSf_2ImqJ-hxgpD400DzPfQgNE_RXhLSDr9PkaQ_PEP-Cmjao0KHqa5I9fkMb1Zr8yPgZYeXfV0XPFzhaIrFDI-mWJzirXZ4dFLH6xY3bUOGFjBgcnLvnqPr6vTbyTlJaRWIg1lgpGB5cEAhWipZ5lLbMlAAYUZ7A8qY5kXJjaFOKc88FVa7CFGgp9ZOOaEUf4F24HlhH-EgLBcWxoO1SiwAe7ggQ-lUsE6CJuIzxMfZrV2KOR5TX9zW_UGaAt1jmLM60qRONMkQmXqthpgb_2l_HAk3tY0Rs_sb7d1NnQSwNtJQan3OFwUwoeOls_BRShcm5BYWoQztR7KPD-jq3wyXoYORFe6vfjtVg2zGAxfThHYztJGaKSoz9HLgnOklefQvA_U6Q2qLp7a-YrumWX7v43-DyggwMn_179d6jR4BuCsHc9EB2lnfbcIbAFBrO-ulBEp9QmNZnc3Q7vHp5dXXWW-SgPJC6F8cxSEm
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFTKAS6I8mpKASOBBAe3sR3HyQEhoCxb-hCHVtpbiB8Lq1bJ0uwK8VN8I-PECSyq4NRbFL89b3s8A_BMSOaktJrmTlqaCMtpbktOObdTFAjG6al_4Hx0nI5Pk48TOVmDn_1bGO9W2fPEllHb2vgz8l2kLG_JJTx-Pf9GfdYof7vap9Do0OLA_fiOJlvzan8P4fuc89H7k3djGrIKUCMU4zTlsTM4QZYrmccy07ljqIOUmS3RFslEmouyZEYpyy1LdGa8hMaWWWaUSZQS2O81uI6CN_YUpSaDgYe8I03D8zxssBuwYWdeV24HZalPVb4i_tosAT6q6nndXKbh_u2o-YfkG92GW0FlJW86HNuANVfdgY3AFBryIkSufnkX7CfEoVYLNYRlIzra-0CW80V55sisIbO2rHEWv4g_-iWc9Ee_JMR3bUjvFE8WNanqinY1sMPgVN_cg9Mr2fD7sI7juU0gLtEi0dgf8sZkirqOcdLlRjltJFo-NgLR725hQoxzn2rjvGgv7hTaOt2eFR4mRYBJBHRoNe9ifPyn_lsPuKGuj9Dd_qgvvhSB4ItSloxpG4tpikhvRG40LkplaelijUwvgk0P9n6ApviN4BFs96hwefHToRh5gb_gKStXL7s6MuOKyQgedJgzTFJ4fzY05yNQKzi1sorVkmr2tY03jiYqqq3x1r-n9QRujE-ODovD_eODh3ATFcu8O6rahvXFxdI9QuVtoR-3FEPg81WT6C_5u1W3
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFSKhLggyqspBYwEEhzcTew4Tg4IAUtoKVQ9UGlvIX4EVq2SpdkV4tf4OsaJE1hUwam3KH573vZ4BuAJF5EVwiiaWWFozA2jmSkZZcxUKBC0VZV74PzxKNk_id_PxGwDfg5vYZxb5cATO0ZtGu3OyCdIWc6Si1k4qbxbxPE0f7n4Rl0GKXfTOqTT6FHk0P74juZb--JgirB-ylj-9tObfeozDFDNZcRowkKrcbJRJkUWilRlNkJ9pExNiXZJypOMl2WkpTTMRLFKtZPW2DJNtdSxlBz7vQJXJa7Y0ZicjcYe8pEk8U_1sMHEY8beoqntHspVl7Z8TRR2GQNchNWzpr1I2_3bafMPKZjfhBtefSWvenzbgg1b34ItzyBa8sxHsX5-G8wx4lOnkWoSpTnNp-_IarEsTy2Zt2TelbXW4Bdxx8CEkeEYmPhYry0ZHOTJsiF1U9O-BnboHezbO3ByKRt-FzZxPLsNxMaKxwr7Qz4ZV6j3aCtspqVVWqAVZALgw-4W2sc7d2k3zoruEk-i3dPvWeFgUniYBEDHVos-3sd_6r92gBvrumjd3Y_m_Evhib8oRRlFyoS8SpAANM-0wkXJNCltqJABBrDtwD4M0Ba_kT2A3QEVLi5-PBYjX3CXPWVtm1VfR6RMRiKAez3mjJPkzrcNTfsA5BpOra1ivaSef-1ij6O5iipsuPPvaT2Ca0icxYeDo8P7cB11zKw_tdqFzeX5yj5APW6pHnYEQ-DzZVPoL_dsWe0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pancreatic+18F-FDG+uptake+is+increased+in+type+2+diabetes+patients+compared+to+non-diabetic+controls&rft.jtitle=PloS+one&rft.au=Bakker%2C+Guido+J&rft.au=%E2%A8%AF+Manon+C+Vanbellinghen&rft.au=Scheithauer%2C+Torsten+P&rft.au=Verchere%2C+C+Bruce&rft.date=2019&rft.pub=Public+Library+of+Science&rft.eissn=1932-6203&rft.volume=14&rft.issue=3&rft.spage=e0213202&rft_id=info:doi/10.1371%2Fjournal.pone.0213202&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon